TY  - GEN
AU  - Koop,A
AU  - Satzger,I
AU  - Alter,M
AU  - Kapp,A
AU  - Hauschild,A
AU  - Gutzmer,R
TI  - Intermittent BRAF-inhibitor therapy is a feasible option: report of a patient with metastatic melanoma
SN  - 1365-2133
PY  - 2015///0114
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Drug Administration Schedule
KW  - Humans
KW  - Indoles
KW  - Male
KW  - Melanoma
KW  - drug therapy
KW  - Proto-Oncogene Proteins B-raf
KW  - antagonists & inhibitors
KW  - Skin Neoplasms
KW  - Sulfonamides
KW  - Vemurafenib
N1  - Publication Type: Case Reports; Letter
UR  - https://doi.org/10.1111/bjd.12615
ER  -